Cervical Cancer
Hematology/Oncology Clinics of North America · 2024-08 · 38 (4) · 771-781
DOI: 10.1016/j.hoc.2024.03.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2024-08. Verfasst von Vikrant V Sahasrabuddhe. Beteiligte Einrichtung: Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 9609 Medical C…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Early Detection of Cancer. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Cervical cancer, caused due to oncogenic types of human papillomavirus (HPV), is a leading preventable cause of cancer morbidity and mortality globally. Chronic, persistent HPV infection-induced cervical precursor lesions, if left undetected and untreated, can progress to invasive cancer. Cervical cancer screening approaches have evolved from cytology (Papanicolaou test) to highly sensitive HPV-based molecular methods and personalized, risk-stratified, management guidelines. Innovations like self-collection of samples to increase screening access, innovative triage methods to optimize management of screen positives, and scalable and efficacious precancer treatment approaches will be key to further enhance the utility of prevention interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 5E-338, Rockville, MD, USA. Electronic address: vikr…
Förderung
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Sahasrabuddhe, V. V. (2024). Cervical Cancer. Hematology/Oncology Clinics of North America, 38(4), 771-781. https://doi.org/10.1016/j.hoc.2024.03.005
Vancouver
Sahasrabuddhe VV. Cervical Cancer. Hematology/Oncology Clinics of North America. 2024;38(4):771-781. doi:10.1016/j.hoc.2024.03.005
BibTeX
@article{Sahasrabuddhe2024,
author = {Sahasrabuddhe, Vikrant V},
title = {Cervical Cancer},
journal = {Hematology/Oncology Clinics of North America},
year = {2024},
volume = {38},
number = {4},
pages = {771--781},
doi = {10.1016/j.hoc.2024.03.005}
}
EUVIMED